Literature DB >> 2421165

Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus.

L Coussens, C Van Beveren, D Smith, E Chen, R L Mitchell, C M Isacke, I M Verma, A Ullrich.   

Abstract

A role for proto-oncogenes in the regulation and modulation of cell proliferation has been suggested by the findings that the B-chain of platelet-derived growth factor (PDGF) is encoded by the proto-oncogene sis and that the erb-B oncogene product is a truncated form of the epidermal growth factor (EGF) receptor. Furthermore, the product of the proto-oncogene fms (c-fms) may be related or identical to the receptor for macrophage colony-stimulating factor (CSF-1). v-fms is the transforming gene of the McDonough strain of feline sarcoma virus (SM-FeSV) and belongs to the family of src-related oncogenes which have tyrosine-specific kinase activity. Furthermore, nucleotide sequence analysis of the v-fms gene product revealed topological properties of a cell-surface receptor protein. To elucidate the features involved in the conversion of a normal cell-surface receptor gene into an oncogenic one, we have now determined the complete nucleotide sequence of a human c-fms complementary DNA. The 972-amino-acid c-fms protein has an extracellular domain, a membrane-spanning region, and a cytoplasmic tyrosine protein kinase domain. Comparison of the feline v-fms and human c-fms sequences reveals that the proteins share extensive homology but have different carboxyl termini.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2421165     DOI: 10.1038/320277a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  139 in total

1.  Distinct Rho GTPase activities regulate epithelial cell localization of the adhesion molecule CEACAM1: involvement of the CEACAM1 transmembrane domain.

Authors:  Bénédicte Fournès; Jennifer Farrah; Melanie Olson; Nathalie Lamarche-Vane; Nicole Beauchemin
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

2.  SH2 domains of the p85 alpha subunit of phosphatidylinositol 3-kinase regulate binding to growth factor receptors.

Authors:  C J McGlade; C Ellis; M Reedijk; D Anderson; G Mbamalu; A D Reith; G Panayotou; P End; A Bernstein; A Kazlauskas
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

3.  RYK, a receptor tyrosine kinase-related molecule with unusual kinase domain motifs.

Authors:  C M Hovens; S A Stacker; A C Andres; A G Harpur; A Ziemiecki; A F Wilks
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

4.  Differential transcription of exon 1 of the human c-fms gene in placental trophoblasts and monocytes.

Authors:  J Visvader; I M Verma
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

5.  Autocrine mechanism for v-sis transformation requires cell surface localization of internally activated growth factor receptors.

Authors:  T P Fleming; T Matsui; C J Molloy; K C Robbins; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

6.  Amino acids bracketing the predicted transmembrane domains of membrane proteins.

Authors:  C Pidgeon; R L Williard; S C Schroeder
Journal:  Pharm Res       Date:  1989-09       Impact factor: 4.200

7.  A frequent EcoRI RFLP demonstrated within the human M-CSF receptor gene (CSFIR).

Authors:  J Felgner; H Kreipe; K Jaquet; K Heidorn; F Zschunke; R Heuss; H J Radzun; M R Parwaresch
Journal:  Nucleic Acids Res       Date:  1991-09-25       Impact factor: 16.971

8.  Differential processing of colony-stimulating factor 1 precursors encoded by two human cDNAs.

Authors:  C W Rettenmier; M F Roussel
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

9.  Early pre-B-cell transformation induced by the v-fms oncogene in long-term mouse bone marrow cultures.

Authors:  G V Borzillo; C J Sherr
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

10.  Frequent expression of genes for receptor tyrosine kinases and their ligands in human pancreatic cancer cells.

Authors:  T Oikawa; J Hitomi; A Kono; E Kaneko; K Yamaguchi
Journal:  Int J Pancreatol       Date:  1995-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.